Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.47%
1,067.36
+4.96
+0.47%
1,062.401,064.141,071.991,061.02
SIXC
Communications
SIXC
Communications
SIXC
-0.54%
603.48
-3.26
-0.54%
606.74606.74609.84602.33
SIXE
Energy
SIXE
Energy
SIXE
+0.54%
1,244.93
+6.72
+0.54%
1,238.211,236.601,247.741,232.10
SIXI
Industrials
SIXI
Industrials
SIXI
+0.68%
1,730.38
+11.77
+0.68%
1,718.611,723.231,741.481,717.47
SIXM
Financials
SIXM
Financials
SIXM
+0.33%
639.47
+2.10
+0.33%
637.37638.27642.30638.27
SIXR
Staples
SIXR
Staples
SIXR
+0.16%
854.95
+1.36
+0.16%
853.59854.05858.19851.34
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.11%
218.56
+0.23
+0.11%
218.33218.33219.73217.15
SIXT
Technology
SIXT
Technology
SIXT
+1.02%
3,631.59
+36.78
+1.02%
3,594.813,620.103,657.473,615.34
SIXU
Utilities
SIXU
Utilities
SIXU
+0.80%
915.77
+7.23
+0.80%
908.54909.50917.35907.07
SIXV
Health care
SIXV
Health care
SIXV
+1.19%
1,512.81
+17.81
+1.19%
1,495.001,499.611,517.101,499.61
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.41%
2,408.21
+9.90
+0.41%
2,398.312,406.822,421.802,404.22
600285:SHA
Henan Lingrui Pharmaceutical Co., Ltd.
CN¥21.37
-0.84%
(-0.18) 1D
May 22, 3:00:03 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600285...
Open
CN¥21.65
High
CN¥21.67
Low
CN¥21.31
Mkt. cap
12.22B
Avg. vol.
8.06M
Volume
5.75M
P/E ratio
15.37
52-wk high
CN¥24.94
52-wk low
CN¥20.30
EPS
CN¥1.39
Shares outstanding
586.45M
No. of employees
3K
News stories
From sources across the web
About Henan Lingrui Pharmaceutical Co., Ltd.
CEO-
Employees2.79K
Founded1992
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.08B
942.16M
812.03M
1.13B
Cost of goods sold
156.10M
184.05M
194.87M
245.62M
Cost of revenue
156.10M
184.05M
194.87M
245.62M
Research and development expenses
40.26M
41.54M
64.52M
31.48M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
591.45M
514.55M
427.97M
563.59M
Operating expense
647.43M
561.41M
503.84M
613.11M
Total operating expenses
803.53M
745.46M
698.71M
858.73M
Operating income
274.92M
196.69M
113.32M
267.34M
Other non operating income
-1.36M
1.01M
-1.78M
-111.14K
EBT including unusual items
297.88M
206.01M
121.91M
285.51M
EBT excluding unusual items
288.03M
211.20M
125.02M
284.47M
Income tax expense
38.74M
28.34M
13.00M
38.07M
Effective tax rate
13.01%
13.76%
10.66%
13.33%
Other operating expenses
13.26M
1.14M
17.18M
9.49M
Net income
257.57M
176.55M
108.57M
246.33M
Net profit margin
23.88%
18.74%
13.37%
21.88%
Earnings per share
-
-
-
-
Interest and investment income
15.57M
15.15M
14.40M
18.00M
Interest expense
-1.09M
-1.66M
-908.91K
-763.97K
Net interest expenses
14.48M
13.48M
13.50M
17.24M
Depreciation and amortization charges
-
-
-
-
EBITDA
297.31M
214.63M
137.12M
291.15M
Gain or loss from assets sale
-4.70M
4.70M
-6.99M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more